标题
Denosumab: A Review in Postmenopausal Osteoporosis
作者
关键词
-
出版物
DRUGS & AGING
Volume 35, Issue 2, Pages 163-173
出版商
Springer Nature
发表日期
2018-02-12
DOI
10.1007/s40266-018-0525-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
- (2017) Steven R Cummings et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement
- (2017) Panagiotis Anagnostis et al. MATURITAS
- Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study
- (2017) M. B. Zanchetta et al. OSTEOPOROSIS INTERNATIONAL
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
- (2017) Henry G Bone et al. Lancet Diabetes & Endocrinology
- Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium
- (2017) A. Fahrleitner-Pammer et al. Archives of Osteoporosis
- Denosumab Reduces Cortical Porosity of the Proximal Femoral Shaft in Postmenopausal Women With Osteoporosis
- (2016) Roger Zebaze et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
- (2016) P. D. Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab compared to other treatments to prevent or treat osteoporosis in individuals at risk of fracture: a systematic review and meta-analysis
- (2016) C. Beaudoin et al. OSTEOPOROSIS INTERNATIONAL
- Postmenopausal osteoporosis
- (2016) Richard Eastell et al. Nature Reviews Disease Primers
- Comparison of proximal femur and vertebral body strength improvements in the FREEDOM trial using an alternative finite element methodology
- (2015) Philippe Zysset et al. BONE
- Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis
- (2015) S. Palacios et al. CLIMACTERIC
- Persistence with denosumab therapy among osteoporotic women in the Canadian patient-support program
- (2015) Alexandra Papaioannou et al. CURRENT MEDICAL RESEARCH AND OPINION
- Indirect comparison of teriparatide, denosumab, and oral bisphosphonates for the prevention of vertebral and nonvertebral fractures in postmenopausal women with osteoporosis
- (2015) Lanling Zhang et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study
- (2015) P. Hadji et al. OSTEOPOROSIS INTERNATIONAL
- Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis
- (2015) L. Karlsson et al. OSTEOPOROSIS INTERNATIONAL
- Mixed Treatment Comparison to Rank Antiresorptive Agents In Preventing New Non Vertebral Fractures In Postmenopausal Osteoporosis
- (2015) U Massafra et al. VALUE IN HEALTH
- Denosumab Rapidly Increases Cortical Bone in Key Locations of the Femur: A 3D Bone Mapping Study in Women With Osteoporosis
- (2014) Kenneth ES Poole et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Clinical Trials Express:Fracture Risk Reduction With Denosumab in Japanese Postmenopausal Women and Men With Osteoporosis: Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)
- (2014) Toshitaka Nakamura et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)
- (2014) T. Sugimoto et al. OSTEOPOROSIS INTERNATIONAL
- The Prevention of Postmenopausal Osteoporotic Fractures: Results of the Health Technology Assessment of a New Antiosteoporotic Drug
- (2014) Chiara de Waure et al. Biomed Research International
- Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study
- (2013) C. Roux et al. BONE
- Femoral and Vertebral Strength Improvements in Postmenopausal Women With Osteoporosis Treated With Denosumab
- (2013) Tony M Keaveny et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab Compared With Ibandronate in Postmenopausal Women Previously Treated With Bisphosphonate Therapy
- (2013) Chris Recknor et al. OBSTETRICS AND GYNECOLOGY
- Cost Effectiveness of Denosumab versus Oral Bisphosphonates for Postmenopausal Osteoporosis in the US
- (2013) Anju Parthan et al. Applied Health Economics and Health Policy
- Comparison of clinical efficacy and safety between denosumab and alendronate in postmenopausal women with osteoporosis: a meta-analysis
- (2012) T. Lin et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Denosumab Treatment in Postmenopausal Women with Osteoporosis Does Not Interfere with Fracture-Healing
- (2012) Silvano Adami et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX
- (2012) Eugene V McCloskey et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Discontinuation of denosumab and associated fracture incidence: Analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) Trial
- (2012) Jacques P Brown et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab Densitometric Changes Assessed by Quantitative Computed Tomography at the Spine and Hip in Postmenopausal Women With Osteoporosis
- (2012) Michael R. McClung et al. JOURNAL OF CLINICAL DENSITOMETRY
- Denosumab Significantly Increases DXA BMD at Both Trabecular and Cortical Sites: Results From the FREEDOM Study
- (2012) Michael A. Bolognese et al. JOURNAL OF CLINICAL DENSITOMETRY
- Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis
- (2012) O. Ström et al. OSTEOPOROSIS INTERNATIONAL
- Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporosis in Canada
- (2012) D. Chau et al. JOURNAL OF MEDICAL ECONOMICS
- Population Pharmacokinetic Meta-Analysis of Denosumab in Healthy Subjects and Postmenopausal Women with Osteopenia or Osteoporosis
- (2011) Liviawati Sutjandra et al. CLINICAL PHARMACOKINETICS
- Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis
- (2011) Michael R McClung et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of denosumab on fracture and bone mineral density by level of kidney function
- (2011) Sophie A Jamal et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bone remodeling in postmenopausal women who discontinued denosumab treatment: Off-treatment biopsy study
- (2011) Jacques P Brown et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk
- (2011) S. Boonen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
- (2011) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impact of clinical fractures on health-related quality of life is dependent on time of assessment since fracture: results from the FREEDOM trial
- (2011) S. Silverman et al. OSTEOPOROSIS INTERNATIONAL
- Microarchitectural deterioration of cortical and trabecular bone: Differing effects of denosumab and alendronate
- (2010) Ego Seeman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies
- (2010) Ian R Reid et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of denosumab on bone turnover markers in postmenopausal osteoporosis
- (2010) Richard Eastell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy
- (2009) David L Kendler et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preference and satisfaction with a 6-month subcutaneous injection versus a weekly tablet for treatment of low bone mass
- (2009) D. L. Kendler et al. OSTEOPOROSIS INTERNATIONAL
- Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial*
- (2008) Jacques P Brown et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKL*
- (2008) Paul J Kostenuik et al. JOURNAL OF BONE AND MINERAL RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started